Genentech on a Discovery Spree with Skyhawk, Convelo and Sosei Heptares Deals
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 7 (Table of Contents)
Published: 22 Jul-2019
DOI: 10.3833/pdr.v2019.i7.2441 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Investing in its long-term pipeline, Genentech has signed three discovery deals with Skyhawk Therapeutics, Sosei Heptares and Convelo Therapeutics for a total potential deal value of US$3 B combined...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS